Enovis CORP
No enriched coverage for $ENOV in the last 7 days.
Conifer Management bought $40.6M of Group 1 Automotive (GPI) shares, while directors of Alpha Metallurgical (AMR), GameStop (GME), Tyson Foods (TSN), and Enovis (ENOV) made notable purchases. Silver Lake sold $47.2M of Dell (DELL) shares, with Dell trading near its 52-week high. Gratitude 2022 Trust sold $32M of AGNT shares, which are near a 52-week low.
Engert Oliver (Chief Administrative Officer) purchased 2,660 shares of Enovis CORP (ENOV) at $18.80 on 2026-09-04.
Enovis Corp. (ENOV) insiders bought shares near a 52-week low, with CEO Damien McDonald acquiring 13,035 shares at $19.10-$19.16. Atara Biotherapeutics (ATRA) director bought 104,166 shares at $9.60. Smith-Midland Corp. (SMID) insiders also made purchases. Illumina (ILMN) director sold $57.2M in shares near a 52-week high. Caris Life Sciences (CRIS) exec sold $14.8M in shares. Okta (OKTA) CFO sold 80,000 shares. Krystal Biotech (KRY) execs sold shares near a 52-week high.
Recent ENOV coverage spans insider activity, financial news and earnings.
In the last 30 days, ENOV insiders filed 4 SEC Form 4 transactions — 4 purchases ($450K) and no sales. The most active reporter was Engert Oliver, Chief Administrative Officer, with 3 filings.
Minor bullish indication.
Insider purchase may signal confidence from senior management, modestly supportive for the stock.
Potential bullish signal from insider buying at low levels.
Small insider purchase signals confidence but limited price impact.
Insider buying may signal confidence, but the modest size limits price impact.
AlphAI scores every news story that mentions ENOV with an AI model for sentiment and relevance, and aggregates insider trades from Enovis CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.
Conifer Management bought $40.6M of Group 1 Automotive (GPI) shares, while directors of Alpha Metallurgical (AMR), GameStop (GME), Tyson Foods (TSN), and Enovis (ENOV) made notable purchases. Silver Lake sold $47.2M of Dell (DELL) shares, with Dell trading near its 52-week high. Gratitude 2022 Trust sold $32M of AGNT shares, which are near a 52-week low.
2 min readEngert Oliver (Chief Administrative Officer) purchased 2,660 shares of Enovis CORP (ENOV) at $18.80 on 2026-09-04.
1 min readEnovis Corp. (ENOV) insiders bought shares near a 52-week low, with CEO Damien McDonald acquiring 13,035 shares at $19.10-$19.16. Atara Biotherapeutics (ATRA) director bought 104,166 shares at $9.60. Smith-Midland Corp. (SMID) insiders also made purchases. Illumina (ILMN) director sold $57.2M in shares near a 52-week high. Caris Life Sciences (CRIS) exec sold $14.8M in shares. Okta (OKTA) CFO sold 80,000 shares. Krystal Biotech (KRY) execs sold shares near a 52-week high.
3 min readEngert Oliver (Chief Administrative Officer) purchased 7,598 shares of Enovis CORP (ENOV) at an average of $19.74 ($19.46–$20.32, $0.15M total) across 2 trades over 2026-09-02 to 2026-09-03.
1 min readMcDonald Damien (Chief Executive Officer) purchased 13,035 shares of Enovis CORP (ENOV) at $19.15 ($0.25M total) on 2026-09-04.
1 min readEnovis (NYSE: ENOV) has made a binding offer to acquire eCential Robotics, a surgical robotics company. The deal is expected to close in Q4 2026, subject to regulatory approvals. eCential's Op.n® platform complements Enovis' technology portfolio, enhancing surgical precision and workflows. Both companies' CEOs expressed excitement about the strategic fit and future growth opportunities.
2 min readEnovis CORP (ENOV) filed an SEC Form 8-K — Results of Operations and Financial Condition. Enovis Announces Second Quarter 2026 Results • Second-quarter sales growth of 3% on a reported basis, 5% organic • Second-quarter Reconstructive sales growth of 8% on a reported basis, 6% organic • Reaffirmed full-year 2026 guidance for revenue, adjusted EBITDA, adjusted EPS, and
6 min readEnovis (NYSE: ENOV) is set to report Q2 earnings Thursday. The company previously reported Q1 revenue of $589.2 million, up 5.4% year on year, and beat EPS and revenue expectations. For Q2, analysts expect revenue growth of 3.1% y/y. Enovis shares are up 18.5% over the past month, with an average analyst price target of $41.58 versus $30.68.
4 min readUBS initiated coverage of four U.S. medtech firms. It assigned Buy ratings to Intuitive Surgical (ISRG) with a $500 price target and Enovis (ENOV) with a $51 target, citing growth drivers and improving fundamentals. UBS gave Inspire Medical Systems (INSP) a Sell rating with a $39 target and Integra LifeSciences (IART) a Neutral rating with a $19 target, citing competition, reimbursement and limited catalysts.
4 min readEnovis (NYSE: ENOV) shares rose about 3.6% after the company said it launched CT-RevitL, a veterinary laser therapy system, in the U.S. Enovis said the photobiomodulation device targets pain management and healing and is available immediately, with international plans later. After the move, shares traded around $26.48.
4 min read
